The infectious disease diagnostics market is expected to grow from US$ 23,890 million in 2021 to US$ 37,943.90 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028
The global veterinary infectious disease diagnostics market size was USD 1.70 Billion in 2021 and is expected to register a revenue CAGR of 9.1% during the forecast period, according to the latest analysis by Emergen Research. Revenue growth of the veterinary infectious disease diagnostics market is driven by factors such as rising number of veterinary practitioners in developed countries, increasing prevalence of transboundary & zoonotic disease, and rising demand for pet insurance, advanced diagnostic devices, companion animal, and animal-derived food products.
Global Veterinary Infectious Disease Diagnostics Market to its report store. The market research report covers an in-depth analysis of Veterinary Infectious Disease Diagnostics Market, taken all impacting factors into account. It covers geographical insights and country insights for 2019 and forecast upto 2026.
According to Straits Research, the global infectious respiratory disease diagnostics market size was valued at USD 24 billion in 2022. It is estimated to reach USD 38.86 billion by 2031, growing at a CAGR of 5.5% during the forecast period (2023–2031).https://straitsresearch.com/report/infectious-respiratory-disease-diagnostics-market/request-sample
According to Straits Research, the global infectious respiratory disease diagnostics market size was valued at USD 24 billion in 2022. It is estimated to reach USD 38.86 billion by 2031, growing at a CAGR of 5.5% during the forecast period (2023–2031). https://straitsresearch.com/report/infectious-respiratory-disease-diagnostics-market/request-sample
Infectious diseases in animals can lead to fatalities if left untreated for long period. Therefore, early diagnosis plays a major role in treatment of animals suffering from these diseases.
Global Infectious Disease Diagnostics Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Infectious Disease Diagnostics industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China) .
Personalized Medicine diagnostics market is expected to grow with a double digit CAGR for the period of 2013 to 2018. It is expected that personalized medicine diagnostics market by technology is going to double by 2018 from its current market size in 2012. In this segment, Point of Care Testing and Molecular Diagnostics segments control the #1 and #2 positions in 2012.
The global molecular diagnostics market is expected to see innovation driven growth. With recent outbreak of infectious. For more mail: vikas@konceptanalytics.com
Infectious disease diagnosis is defined as a laboratory test, which is executed with the help of skilled technicians and physicians to diagnose infectious diseases. It is a diagnostic procedure in which the causative organism of an infectious disease is characterized and identified. The sample of urine, blood, mucus, or other body fluids are analyzed to provide information about the causative organism by the use of various diagnosis procedure and instruments.
The rising incidence of infectious diseases and shift in focus from centralized laboratories to decentralized (POC) point-of-care testing is driving the market demand.
According to the latest research report by IMARC Group, The Brazil in-vitro diagnostics market size is projected to exhibit a growth rate (CAGR) of 5.68% during 2024-2032. More Info:- https://www.imarcgroup.com/brazil-in-vitro-diagnostics-market
According to the latest research report by IMARC Group, The global veterinary diagnostics market size reached US$ 6.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.6 Billion by 2032, exhibiting a growth rate (CAGR) of 7.3% during 2024-2032. More Info:- https://www.imarcgroup.com/veterinary-diagnostics-market
According to the latest research report by IMARC Group, The global veterinary molecular diagnostics market size reached US$ 690.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,391.9 Million by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2024-2032. More Info:- https://www.imarcgroup.com/veterinary-molecular-diagnostics-market
According to the latest research report by IMARC Group, The global women's health diagnostics market size reached US$ 29.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 52.6 Billion by 2032, exhibiting a growth rate (CAGR) of 6.6% during 2024-2032. More Info:- https://www.imarcgroup.com/womens-health-diagnostics-market
Bharat Book Bureau provides the report, on “ Diagnostics industry analysis Global Immunoprotein Diagnostic Testing Market 2015-2019” This Report market research analyst has estimated the infectious disease testing segment to be the largest market segment during the forecast period. https://www.bharatbook.com/diagnostics-market-research-reports-739734/global-immunoprotein-diagnostic-testing.html
According to the latest research report by IMARC Group, The global point of care molecular diagnostics market size reached US$ 3.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.4 Billion by 2032, exhibiting a growth rate (CAGR) of 9.2% during 2024-2032. More Info:- https://www.imarcgroup.com/point-of-care-molecular-diagnostics-market
Major players in the drug delivery devices market are F. Hoffmann-La Roche Ltd, 3M Company, Pfizer Inc, Baxter International, BD, Novartis AG....@ @ https://bit.ly/3wHH7ZH
The global Molecular Diagnostics Market is highly fragmented due to the presence of a various large number of players which forms a competitive environment. The report entails all-inclusive information associated with the latest market updates such as new ideas, market size, opportunity, growth path and trends for the forecast period of 2019-2025 to gain competitive edge across the globe. This report also highlights various important strategic mergers and acquisitions, company overview, financial details, and the latest development undertaken.
According to the latest research report by IMARC Group, The global poultry diagnostics market size reached US$ 441.8 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 791.2 Million by 2028, exhibiting a growth rate (CAGR) of 10.2% during 2023-2028. More Info:- https://www.imarcgroup.com/poultry-diagnostics-market
According to the latest research report by IMARC Group, The global companion diagnostics market size reached US$ 5.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 11.7 Billion by 2027, exhibiting a growth rate (CAGR) of 14.78% during 2022-2027. More Info:- https://www.imarcgroup.com/companion-diagnostics-market
The global molecular diagnostics market was worth $8.62 billion in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 8.82% and reach $12.09 billion by 2023. Read More @ https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-market-global-report-2020-covid-19-implications-and-growth
Looking forward, the poultry diagnostics market value is projected to reach a strong growth during the forecast period (2022-2027). More info:- https://www.imarcgroup.com/poultry-diagnostics-market
The Business Research Company offers molecular biology enzymes and kits and reagents market research report 2023 with industry size, share, segments and market growth
Global Drug Delivery Devices Market by The Business Research Company is segmented as Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery https://bit.ly/3DV5STx
TBRC global lateral flow immunoassay (LFIA) based rapid test market report includes competitive assay, sandwich assay, multiplex detection assay https://bit.ly/3vV6IgR
Complete report on In-Vitro Diagnostics (IVD) market spread across 81 pages providing 4 company profiles and 3 tables and 48 charts is now available at http://www.marketreportsonline.com/547317.html.
Infinium Global Research has added a new report on Global Infectious Disease Diagnostic Market. The report predicts the market size of Infectious Disease Diagnostic is expected to reach XX billion by 2023.
The report offers insightful and detailed information regarding key players operating in the Point of Care Testing for Infectious Diseases Market & their future strategies.
The global hematology diagnostic devices and equipment market is expected to grow from $2.79 billion in 2020 to $4.31 billion in 2021 at a compound annual growth rate (CAGR) of 54.5%.
Increase in burden of cancer globally, growing demand for personalized medicine and targeted therapy coupled with increase in adoption of drug diagnostics co-development model by industry players are the key factors driving the global companion diagnostics market.
In this report, the global Point of Care Diagnostics Market was valued at US$ 17,886.3 Mn 2018 and is projected to reach US$ 30,175.3 Mn by the end of 2027, growing at a CAGR of 6.8% during the period 2018 to 2027
The report on Infectious Disease Testing Market by Infinium Global Research analyzes the Infectious Disease Testing Market over the period of 2017 to 2023. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in Global Infectious Disease Testing Market. It will help a lot of decision makers to develop strategies and find new opportunities in the Global Infectious Disease Testing Market.
Molecular diagnostics, a rapidly evolving segment of the healthcare industry, utilizes molecular biology techniques to analyze biological markers at the molecular level. This approach enables precise detection, diagnosis, and monitoring of various diseases, leading to personalized treatment strategies and improved patient outcomes. The global molecular diagnostics market demonstrates robust growth, driven by technological advancements, increasing prevalence of infectious diseases and cancer, and growing demand for rapid and accurate diagnostic solutions. The global molecular diagnostics market is forecast to expand at a CAGR of 6.2% and thereby increase from a value of US$23.2 Bn in 2024, to US$35.6 Bn by the end of 2031.
Get a sample brochure @ http://tinyurl.com/jpkxcrw In vitro diagnostics (IVD) is a method used for detection and identification of diseases in an artificial environment using samples such as blood, urine, stool, tissues and other body fluids, which are derived from the human body. IVD includes several techniques such as immunodiagnostic, infectious diseases testing, blood testing, clinical chemistry, molecular diagnosis and other such techniques. Considerable increase in the number of chronic and infectious diseases, growing awareness towards healthcare solutions and technological advancements in healthcare industry encouraged doctors and researchers to shift their focus from traditional diagnostic methods to personalized medicines.
The paper diagnostics Market Report offers a complete picture of industry trends and factors along with quantitative data based on historical data and from various sources. Apart from this, the report also provides the market outlook, growth, share, size, opportunity and forecast during 2019-2025. Further, the report focuses on competitive landscape including company profiles of leading key players along with industry demand, future capacities, key mergers & acquisitions, financial overview in the global market of paper diagnostics.
The field of diagnostics has seen significant technical progress. In the past, diagnostic techniques were costly, time-consuming, and protracted. Diagnostic procedures have taken less time with the introduction of digital platforms into the medical industry, and the procedures have grown extremely robust and fast. However, not every location has access to digital technology, particularly in developing nations. Since these technologies are quite expensive, several nations are searching for diagnostic methods that are less expensive. In order to address these rural conditions, paper diagnosis becomes necessary. This paper strip has layers of chemicals and antibodies that change color when they come into contact with the sample.
European Aquaculture Vaccines Market size is poised to exceed USD 170.3 million by 2027, according to a latest forecast report by Graphical Research. Surging prevalence of bacterial and viral infections is the major driving factor of the market revenue. Infectious disease is one of the most vital limiting factors in aquaculture. For most warmwater aquaculture facilities, disease prevention consists of good husbandry techniques. When disease outbreak occurs, diagnostics are conducted to determine the actual cause and then the fish are given oral treatment that is an immersion or in rare cases injection treatment. This leads to huge losses both in terms of yield and economic. Thus, to limit the economic losses, the use of vaccines is increasing across the region.
Global Market Insights recently added a detailed market research study focused on the Global Cancer Diagnostics Market across the global, regional and country level. The report provides 360° analysis of Cancer Diagnostics Market from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Cancer Diagnostics Market and estimates the future trend of industry on the basis of this detailed study.
Increasing investment in R&D in molecular diagnostics, new product development, and rising prevalence of targeted diseases are some key factors driving market revenue growth.
This Future Market Insights (FMI) report examines the ‘Veterinary Molecular Diagnostics Market: Global Industry Analysis (2013-2017) and Forecast (2018-2026)’. The primary objective of the report is to offer updates and information related to market opportunities in the global veterinary molecular diagnostics market.
According to Straits Research, the global digital pcr market size was valued at USD 555 Million in 2021. It is projected to reach from USD XX Million in 2022 to USD 1236 Million by 2030, growing at a CAGR of 9.3% during the forecast period (2022–2030). https://straitsresearch.com/report/digital-pcr-market/request-sample
According to Straits Research, the global molecular diagnostics market size was valued at USD 14.93 billion in 2023. It is estimated to reach USD 33.40 billion by 2032, growing at a CAGR of 9.36% during the forecast period (2024–2032). https://straitsresearch.com/report/molecular-diagnostics-market/request-sample
The study segments In Vitro Diagnostics (IVD) industry in light of major classification such as product type, potential markets, application, and end-user.